8-K: Current report
8-K/A: Current report (Amendment)
8-K: Current report
8-K: Reviva Reports Second Quarter 2024 Financial Results and Recent Business Highlights
8-K: Current report
8-K: Current report
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
8-K: Current report
8-K: Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights
Reviva Pharmaceuticals | 8-K: Current report
Reviva Pharmaceuticals | 8-K: Current report
Reviva Pharmaceuticals | 8-K: Current report
Reviva Pharmaceuticals | NT 10-K: Others
Reviva Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Reviva Pharmaceuticals | 8-K: Current report
Reviva Pharmaceuticals | 8-K: Current report
Reviva Pharmaceuticals | 8-K/A: Current report (Amendment)
Reviva Pharmaceuticals | 8-K: Reviva Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Reviva Pharmaceuticals | 8-K: Current report
Reviva Pharmaceuticals | DEF 14A: Definitive information statements
No Data
No Data